Nektar Therapeutics (NKTR) Asset Utilization Ratio (2011 - 2026)

Nektar Therapeutics' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.11 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 65.78% year-over-year to 0.11 in Q1 2026; TTM through Mar 2026 was 0.11, a 65.78% decrease from a year earlier, with the FY2025 full-year figure at 0.19, down 32.59% from the prior year.
• Asset Utilization Ratio eased to 0.11 in Q1 2026 per NKTR's latest filing, from 0.19 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.32 in Q2 2025 and bottomed at 0.1 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 0.19 (2025), against an average of 0.2.
• Across the five-year window, Asset Utilization Ratio soared 73.79% in 2023 and tumbled 65.78% in 2026, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.12 in 2022, then surged by 73.79% to 0.21 in 2023, then jumped by 50.0% to 0.32 in 2024, then tumbled by 40.99% to 0.19 in 2025, then tumbled by 43.85% to 0.11 in 2026.
• Per Business Quant, the three latest NKTR Asset Utilization Ratio figures stand at 0.11 (Q1 2026), 0.19 (Q4 2025), and 0.25 (Q3 2025).